Pivotal bioVenture Partners Investment Advisor LLC

**Pivotal bioVenture Partners Investment Advisor LLC** manages $259M across a concentrated portfolio of 12 positions, signaling a focused approach within the biotechnology sector. The fund exhibits significant conviction in its top holdings, with PCVX representing the largest allocation at $63.3M. Further substantial exposure is evident in STT-PG ($45.7M) and ARQT ($39.7M), underpinning a deep-value or growth thesis across key drug discovery areas. This concentrated structure suggests active, high-conviction capital deployment within specialized life science opportunities.

📌 Top Holdings